Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Siltuximab by Recordati for Pain: Likelihood of Approval
Siltuximab is under clinical development by Recordati and currently in Phase II for Pain. According to GlobalData, Phase II drugs...